Related references
Note: Only part of the references are listed.Reference intervals of spinal mobility measures in normal individuals: the mobility study
Sofia Ramiro et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Is Spinal Mobility in Patients With Spondylitis Determined By Age, Structural Damage, and Inflammation?
Jerusalem Calvo-Gutierrez et al.
ARTHRITIS CARE & RESEARCH (2015)
Validation of a new objective index to measure spinal mobility: the University of Cordoba Ankylosing Spondylitis Metrology Index (UCOASMI)
Juan L. Garrido-Castro et al.
RHEUMATOLOGY INTERNATIONAL (2014)
Normative values for the Bath Ankylosing Spondylitis Metrology Index in a UK population
Lucy Chilton-Mitchell et al.
RHEUMATOLOGY (2013)
An exploration of the inter- and intra-rater reliability of the Bath Ankylosing Spondylitis Metrology Index
Jane H. Martindale et al.
CLINICAL RHEUMATOLOGY (2012)
Comparison of three methods for calculating the Bath Ankylosing Spondylitis Metrology Index in a randomized placebo-controlled study
Desiree van der Heijde et al.
ARTHRITIS CARE & RESEARCH (2012)
Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis
Pedro Machado et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Thoracoabdominal motion in ankylosing spondylitis: association with standardised clinical measures and response to therapy
G. E. Tzelepis et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis
J. Sieper et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
The Bath metrology index as assessed by a trained and an untrained rater in patients with spondylarthropathy: a study of intra- and inter-rater agreements
O. R. Madsen et al.
CLINICAL RHEUMATOLOGY (2009)
Persistent clinical efficacy and safety of anti-tumour necrosis factor a therapy with infliximab in patients with ankylosing spondylitis over 5 years:: evidence for different types of response
J. Braun et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Proposal of a linear definition of the Bath Ankylosing Spondylitis Metrology Index (BASMI) and comparison with the 2-step and 10-step definitions
D. van der Heijde et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Development and validation of the Edmonton Ankylosing Spondylitis Metrology Index
Walter P. Maksymowych et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
Efficacy and safety of adalimumab in patients with ankylosing spondylitis - Results of a multicenter, randomized, double-blind, placebo-controlled trial
Desiree van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2006)
Assessment in ankylosing spondylitis International Working Group/spondylitis association of America recommendations for conducting clinical trials in ankylosing spondylitis
D van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2005)
Development and preselection of criteria for short term improvement after anti-TNFα treatment in ankylosing spondylitis
J Brandt et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Spinal mobility in ankylosing spondylitis: reliability, validity and responsiveness
KL Haywood et al.
RHEUMATOLOGY (2004)
Evaluation of the smallest detectable difference in outcome or process variables in ankylosing spondylitis
GR Auleley et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2002)
Clinical assessment of spinal mobility measurements in ankylosing spondylitis: A compact set for follow-up and trials?
JV Viitanen et al.
CLINICAL RHEUMATOLOGY (2000)
Share Paper
